Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Viral vectors for dendritic cell-based immunotherapy
Autore:
Jenne, L; Schuler, G; Steinkasserer, A;
Indirizzi:
Univ Erlangen Nurnberg, Dept Dermatol, D-91052 Erlangen, Germany Univ Erlangen Nurnberg Erlangen Germany D-91052 -91052 Erlangen, Germany
Titolo Testata:
TRENDS IN IMMUNOLOGY
fascicolo: 2, volume: 22, anno: 2001,
pagine: 102 - 107
SICI:
1471-4906(200102)22:2<102:VVFDCI>2.0.ZU;2-6
Fonte:
ISI
Lingua:
ENG
Soggetto:
CYTOTOXIC T-LYMPHOCYTES; MEDIATED GENE-TRANSFER; SERUM-FREE CONDITIONS; HERPES-SIMPLEX VIRUS; STIMULATORY CAPACITY; RECOMBINANT ADENOVIRUS; IMMUNE EVASION; EFFICIENT; EXPRESSION; MATURATION;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
47
Recensione:
Indirizzi per estratti:
Indirizzo: Steinkasserer, A Univ Erlangen Nurnberg, Dept Dermatol, Hartmannstr 14, D-91052 Erlangen, Germany Univ Erlangen Nurnberg Hartmannstr 14 Erlangen Germany D-91052
Citazione:
L. Jenne et al., "Viral vectors for dendritic cell-based immunotherapy", TRENDS IMMU, 22(2), 2001, pp. 102-107

Abstract

Transduction of dendritic cells (DCs) by viral vectors genetically engineered to express tumor-associated antigens (TAAs) or cytokines can produce a high level of transgene expression and is an attractive approach for DC-based immunotherapy. Ex vivo transduction allows the control of DC quality, antigen quantity and site of DC reinjection. This review evaluates the viral vectors currently being developed for use in DC-based immunotherapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/02/20 alle ore 06:15:47